Donor regulatory T-cell therapy to prevent graft-versus-host disease.

Saved in:
Bibliographic Details
Title: Donor regulatory T-cell therapy to prevent graft-versus-host disease.
Authors: Meyer EH; Stanford Blood and Marrow Transplantation and Cellular Therapy Division, Stanford School of Medicine, Stanford University, Stanford, CA.; Cellular Immune Tolerance Program, Stanford Department of Medicine, Stanford University, Stanford, CA., Pavlova A; Stanford Blood and Marrow Transplantation and Cellular Therapy Division, Stanford School of Medicine, Stanford University, Stanford, CA.; Orca Bio, Menlo Park, CA., Villar-Prados A; Stanford Blood and Marrow Transplantation and Cellular Therapy Division, Stanford School of Medicine, Stanford University, Stanford, CA.; Cellular Immune Tolerance Program, Stanford Department of Medicine, Stanford University, Stanford, CA., Bader C; Stanford Blood and Marrow Transplantation and Cellular Therapy Division, Stanford School of Medicine, Stanford University, Stanford, CA.; Cellular Immune Tolerance Program, Stanford Department of Medicine, Stanford University, Stanford, CA., Xie B; Stanford Blood and Marrow Transplantation and Cellular Therapy Division, Stanford School of Medicine, Stanford University, Stanford, CA.; Cellular Immune Tolerance Program, Stanford Department of Medicine, Stanford University, Stanford, CA., Muffly L; Stanford Blood and Marrow Transplantation and Cellular Therapy Division, Stanford School of Medicine, Stanford University, Stanford, CA., Kim P; Stanford Blood and Marrow Transplantation and Cellular Therapy Division, Stanford School of Medicine, Stanford University, Stanford, CA.; Cellular Immune Tolerance Program, Stanford Department of Medicine, Stanford University, Stanford, CA., Sutherland K; Stanford Blood and Marrow Transplantation and Cellular Therapy Division, Stanford School of Medicine, Stanford University, Stanford, CA.; Cellular Immune Tolerance Program, Stanford Department of Medicine, Stanford University, Stanford, CA., Bharadwaj S; Stanford Blood and Marrow Transplantation and Cellular Therapy Division, Stanford School of Medicine, Stanford University, Stanford, CA., Dahiya S; Stanford Blood and Marrow Transplantation and Cellular Therapy Division, Stanford School of Medicine, Stanford University, Stanford, CA.; Cellular Immune Tolerance Program, Stanford Department of Medicine, Stanford University, Stanford, CA., Frank M; Stanford Blood and Marrow Transplantation and Cellular Therapy Division, Stanford School of Medicine, Stanford University, Stanford, CA., Arai S; Stanford Blood and Marrow Transplantation and Cellular Therapy Division, Stanford School of Medicine, Stanford University, Stanford, CA.; Cellular Immune Tolerance Program, Stanford Department of Medicine, Stanford University, Stanford, CA., Johnston L; Stanford Blood and Marrow Transplantation and Cellular Therapy Division, Stanford School of Medicine, Stanford University, Stanford, CA., Miklos D; Stanford Blood and Marrow Transplantation and Cellular Therapy Division, Stanford School of Medicine, Stanford University, Stanford, CA., Rezvani A; Stanford Blood and Marrow Transplantation and Cellular Therapy Division, Stanford School of Medicine, Stanford University, Stanford, CA., Shiraz P; Stanford Blood and Marrow Transplantation and Cellular Therapy Division, Stanford School of Medicine, Stanford University, Stanford, CA., Sidana S; Stanford Blood and Marrow Transplantation and Cellular Therapy Division, Stanford School of Medicine, Stanford University, Stanford, CA., Shizuru J; Stanford Blood and Marrow Transplantation and Cellular Therapy Division, Stanford School of Medicine, Stanford University, Stanford, CA., Weng WK; Stanford Blood and Marrow Transplantation and Cellular Therapy Division, Stanford School of Medicine, Stanford University, Stanford, CA.; Cellular Immune Tolerance Program, Stanford Department of Medicine, Stanford University, Stanford, CA., Agrawal V; City of Hope, Blood and Marrow Transplantation, Duarte, CA., Putnam A; Orca Bio, Menlo Park, CA., Fernhoff N; Orca Bio, Menlo Park, CA., Tamarisis J; Department of Biomedical Data Sciences, Stanford University, Stanford, CA., Lu Y; Department of Biomedical Data Sciences, Stanford University, Stanford, CA., Pawar RD; Division of Immunology and Rheumatology, Stanford University, Stanford, CA., McClellan JS; Orca Bio, Menlo Park, CA., Lowsky R; Stanford Blood and Marrow Transplantation and Cellular Therapy Division, Stanford School of Medicine, Stanford University, Stanford, CA.; Cellular Immune Tolerance Program, Stanford Department of Medicine, Stanford University, Stanford, CA., Negrin RS; Stanford Blood and Marrow Transplantation and Cellular Therapy Division, Stanford School of Medicine, Stanford University, Stanford, CA.; Cellular Immune Tolerance Program, Stanford Department of Medicine, Stanford University, Stanford, CA.
Source: Blood [Blood] 2025 May 01; Vol. 145 (18), pp. 2012-2024.
Publication Type: Journal Article; Clinical Trial, Phase II
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1528-0020
DOI:10.1182/blood.2024026446